Filtros de búsqueda

Lista de obras de

52-Week Efficacy of Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis Who Failed Corticosteroids and/or Immunosuppressants

artículo científico publicado el 1 de julio de 2013

Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis ⬇️

artículo científico publicado el 4 de noviembre de 2011

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

artículo científico publicado en 2011

Adalimumab induces deep remission in patients with Crohn's disease.

artículo científico publicado en 2013

Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis

artículo científico publicado en 2013

Agreement of site and central readings of ileocolonoscopic scores in Crohn's disease: comparison using data from the EXTEND trial

artículo científico publicado en 2015

Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn's Disease: Results from the EXTEND Trial

artículo científico publicado en 2016

Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA.

artículo científico publicado en 2017

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

artículo científico publicado en 2017

Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease

artículo científico publicado en 2020

Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

artículo científico publicado en 2013

Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis.

artículo científico publicado en 2017

Exploring the use of adalimumab for patients with moderate Crohn's disease: subanalyses from induction and maintenance trials

artículo científico publicado en 2013

Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis

artículo científico publicado en 2017

Four-year maintenance treatment with adalimumab in patients with moderately to severely active ulcerative colitis: Data from ULTRA 1, 2, and 3.

artículo científico publicado en 2014

Increased risk of malignancy with adalimumab combination therapy, compared with monotherapy, for Crohn's disease

artículo científico publicado en 2013

Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease

artículo científico publicado en 2014

Performance of Crohn's disease Clinical Trial Endpoints based upon Different Cutoffs for Patient Reported Outcomes or Endoscopic Activity: Analysis of EXTEND Data

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda